Alzheimer's Disease at NYSCF

Page 1

ALZHEIMER’S DISEASE Alzheimer’s drugs are failing clinical trials, because we still do not understand what causes this complex disease.

44

Million People

worldwide have Alzheimer’s or a related dementia

In 2018, Alzheimer’s

cost the United States

$277 Billion

The cost of treating Alzheimer’s is expected to quadruple, to more than

$1 Trillion

in the U.S. by 2030, if no breakthrough treatments reach the market.

We haven’t had the tools we need to make real progress. Now, we do.

At NYSCF, we use the power of human patient stem

cells to study Alzheimer’s, which is bringing a paradigm shift to the entire field.

Alzheimer’s is a human disease, and we need human cells to really understand what causes it, develop more effective treatments, and find a cure. We have made patient stem cells from

9

DIFFERENT SUBTYPES

OF ALZHEIMER’S DISEASE,

making them available to scientists around the world and collaborating with

over

40 INSTITUTIONS

.


Turn static files into dynamic content formats.

Create a flipbook
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.